Eaton Vance Worldwide Health Sci A
(ETHSX)
US Markets Close In1 hr 41 min
AdChoices
13.57
+0.25
+1.88%
:

Previous Close

13.32

Net Assets

924.30M

Yield

0.47%

Front load

5.75

Expenses

1.39%

Category

Health

Morningstar Risk

Average

Morningstar Rating ★★
AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Top Rated Funds
  • Fund vs. Category
Quarterly Returns
  • Annual

  • ETHSX

  • Category

    • 2013

    • 44.56%

    • -

    • 2012

    • 15.49%

    • -

    • 2011

    • 4.75%

    • -

    • 2010

    • 11.13%

    • -

    • 2013

    • 2012

    • 2011

      • Q1

      • 14.87%

      • 10.02%

      • 4.17%

      • Q2

      • 1.19%

      • 3.58%

      • 8.62%

      • Q3

      • 14.16%

      • 4.74%

      • -11.72%

      • Q4

      • 8.94%

      • -3.25%

      • 4.87%

      Composition
      Sector Weightings
      Equity Investment Style
      The two dimensions of the Fund Style box measure the average size of companies that have been in the FUND, from the top to bottom, and the average valuation characteristics of the FUND's past stock holdings, from left to right.
      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Roche Holding AG Dividend Right Cert.

        • 5.72

        • 293,000

        • 0

        • Gilead Sciences Inc

        • 4.31

        • 600,000

        • 0

        • AbbVie Inc

        • 4.21

        • 1,140,000

        • 0

        • Bristol-Myers Squibb Company

        • 4.16

        • 1,230,000

        • 0

        • HCA Holdings Inc

        • 3.93

        • 842,000

        • -213,000

        • Merck & Co Inc

        • 3.74

        • 932,000

        • 0

        • Amgen Inc

        • 3.65

        • 392,000

        • 0

        • Regeneron Pharmaceuticals Inc

        • 3.58

        • 153,000

        • 20,500

        • Biogen Idec Inc

        • 3.43

        • 149,600

        • 0

        • Medivation Inc

        • 3.18

        • 522,000

        • 0

        • Name

        • Rating

        • YTD Return %

          • Prudential Jennison Health Sciences Z

          • ★★★★★
          • 18.82

          • VALIC Company I Health Sciences

          • ★★★★★
          • 19.62

          • Prudential Jennison Health Sciences A LW

          • ★★★★★
          • 18.54

          • T. Rowe Price Health Sciences

          • ★★★★★
          • 19.88

          • BlackRock Health Sciences Opps Inv A LW

          • ★★★★
          • 18.15

          • BlackRock Health Sciences Opps Inv C

          • ★★★★
          • 17.47

          • Fidelity Advisor® Biotechnology A

          • ★★★★
          • 19.77

          • Janus Global Life Sciences D

          • ★★★★
          • 20.52

          • Prudential Jennison Health Sciences B

          • ★★★★
          • 17.87

          • Janus Global Life Sciences A

          • ★★★★
          • 20.34

          • Name

          • ETHSX

          • Category

            • Expense Ratio

            • 1.39%

            • 1.45%

            • Net Assets

            • 924.30M

            • 711.24M

            • Dividend Yield

            • 0.66%

            • 0.61

            • Price/Book

            • 3.79

            • 4.82

            • Price/Sales

            • 3.01

            • 3.25

            • Price/Cash Flow

            • 17.28

            • 19.29

            Profile

            Name of Issuer

            Eaton Vance

            Fund Style

            Open

            Fund Manager

            Samuel Isaly

            Investment Style

            Large Growth

            The investment seeks long-term capital growth by investing in a worldwide and diversified portfolio of health sciences companies. The fund normally invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It concentrates (that is, invests at least 25% of its assets) its investments in medical research and the health care industry. The fund may invest up to 5% of its total assets in royalty bonds.

            Purchase Information

            Initial Purchase 1,000
            Initial Purchase: IRA NA
            Initial Purchase: AIP 1,000
            Front load 5.75
            Back Load 5.75

            Inception

            7/26/1985